301230 泓博医药
已收盘 06-25 15:00:00
资讯
新帖
简况
6月23日泓博医药涨5.46%，长城消费增值混合A基金重仓该股
证券之星 · 06-23 16:42
6月23日泓博医药涨5.46%，长城消费增值混合A基金重仓该股
股市必读：泓博医药（301230）6月17日董秘有最新回复
证券之星 · 06-18
股市必读：泓博医药（301230）6月17日董秘有最新回复
泓博医药：CADD/AIDD技术深度嵌入到业务环节
证券之星 · 06-17
泓博医药：CADD/AIDD技术深度嵌入到业务环节
泓博医药(301230)6月10日股东户数2.05万户，较上期减少0.83%
证券之星 · 06-12
泓博医药(301230)6月10日股东户数2.05万户，较上期减少0.83%
泓博医药：截至2026年6月10日股东户数为20,521户
证券之星 · 06-12
泓博医药：截至2026年6月10日股东户数为20,521户
泓博医药：2025年营业收入及盈利能力均实现同比改善
证券之星 · 06-12
泓博医药：2025年营业收入及盈利能力均实现同比改善
泓博医药：截至2026年5月29日，公司的股东户数为20,692户
证券之星 · 06-10
泓博医药：截至2026年5月29日，公司的股东户数为20,692户
泓博医药（301230）披露2024年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告，5月28日股价上涨0.36%
证券之星 · 05-28
泓博医药（301230）披露2024年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告，5月28日股价上涨0.36%
泓博医药（301230）披露2025年度持续督导定期现场检查报告，5月19日股价上涨1.21%
证券之星 · 05-19
泓博医药（301230）披露2025年度持续督导定期现场检查报告，5月19日股价上涨1.21%
股市必读：泓博医药(301230)股东户数2.29万户，较上期增加0.81%
证券之星 · 05-18
股市必读：泓博医药(301230)股东户数2.29万户，较上期增加0.81%
泓博医药（301230）披露2025年度网上业绩说明会公告，5月15日股价下跌3.14%
证券之星 · 05-15
泓博医药（301230）披露2025年度网上业绩说明会公告，5月15日股价下跌3.14%
泓博医药：截至2026年5月8日股东户数为22,920户
证券之星 · 05-15
泓博医药：截至2026年5月8日股东户数为22,920户
5月14日泓博医药跌7.41%，长城消费增值混合A基金重仓该股
证券之星 · 05-14
5月14日泓博医药跌7.41%，长城消费增值混合A基金重仓该股
泓博医药（301230）披露关于认购基金份额暨关联交易并完成工商变更登记的公告，5月7日股价上涨2.61%
证券之星 · 05-07
泓博医药（301230）披露关于认购基金份额暨关联交易并完成工商变更登记的公告，5月7日股价上涨2.61%
每周股票复盘：泓博医药（301230）Q1净利增98.59%
证券之星 · 05-03
每周股票复盘：泓博医药（301230）Q1净利增98.59%
图解泓博医药一季报：第一季度单季净利润同比增长98.59%
证券之星 · 04-29
图解泓博医药一季报：第一季度单季净利润同比增长98.59%
4月22日泓博医药涨9.80%，长城消费增值混合A基金重仓该股
证券之星 · 04-22
4月22日泓博医药涨9.80%，长城消费增值混合A基金重仓该股
股市必读：泓博医药(301230)股东户数2.39万户，较上期减少4.36%
证券之星 · 04-20
股市必读：泓博医药(301230)股东户数2.39万户，较上期减少4.36%
泓博医药：截至2026年4月10日股东户数为23,935户
证券之星 · 04-17
泓博医药：截至2026年4月10日股东户数为23,935户
泓博医药：公司与药石科技未开展相关合作
证券日报网 · 04-03
泓博医药：公司与药石科技未开展相关合作
加载更多
公司概况
公司名称：
上海泓博智源医药股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-11-01
主营业务：
上海泓博智源医药股份有限公司的主营业务是药物发现、制药工艺的研究开发以及原料药中间体的商业化生产。公司的主要产品是药物化学、合成化学、药物代谢动力学、工艺化学、工艺开发、药学研究、定制化生产、自主产品生产。
发行价格：
40.00
{"stockData":{"symbol":"301230","market":"SZ","secType":"STK","nameCN":"泓博医药","latestPrice":36.69,"timestamp":1782370983000,"preClose":37,"halted":0,"volume":8129407,"delay":0,"changeRate":-0.0084,"floatShares":126000000,"shares":140000000,"eps":0.3303,"marketStatus":"已收盘","change":-0.31,"latestTime":"06-25 15:00:00","open":36.81,"high":37.44,"low":35.13,"amount":295000000,"amplitude":0.0624,"askPrice":36.7,"askSize":32,"bidPrice":36.69,"bidSize":55,"shortable":0,"etf":0,"ttmEps":0.3303,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782437400000},"marketStatusCode":5,"adr":0,"adjPreClose":37,"symbolType":"stock","openAndCloseTimeList":[[1782351000000,1782358200000],[1782363600000,1782370800000]],"highLimit":40.7,"lowLimit":33.3,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":139586605,"isCdr":false,"pbRate":5.01,"roa":"--","peRate":111.080836,"roe":"2.34%","epsLYR":0.25,"committee":0.382594,"marketValue":5121000000,"turnoverRate":0.0647,"status":1,"floatMarketCap":4609000000},"requestUrl":"/m/hq/s/301230","defaultTab":"news","newsList":[{"id":"2645173881","title":"6月23日泓博医药涨5.46%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645173881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645173881?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:42","pubTimestamp":1782204137,"startTime":"0","endTime":"0","summary":"证券之星消息，6月23日泓博医药涨5.46%，收盘报37.09元，换手率8.57%，成交量10.76万手，成交额3.95亿元。重仓泓博医药的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300028187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644721725","title":"股市必读：泓博医药（301230）6月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2644721725","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644721725?lang=zh_cn&edition=full","pubTime":"2026-06-18 02:49","pubTimestamp":1781722150,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，泓博医药报收于33.53元，下跌0.42%，换手率2.24%，成交量2.81万手，成交额9421.07万元。CADD/AIDD技术作为公司传统研发服务的赋能工具，其价值主要体现在提升服务效率、缩短研发周期、增强复杂分子交付能力等方面，而非直接产生大规模收入。截至2025年12月底，公司CADD/AIDD技术平台已累计为104个新药项目提供技术支持，其中8个项目已进入临床实验阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800001897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644746701","title":"泓博医药：CADD/AIDD技术深度嵌入到业务环节","url":"https://stock-news.laohu8.com/highlight/detail?id=2644746701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644746701?lang=zh_cn&edition=full","pubTime":"2026-06-17 20:53","pubTimestamp":1781700785,"startTime":"0","endTime":"0","summary":"CADD/AIDD技术作为公司传统研发服务的赋能工具，其价值主要体现在提升服务效率、缩短研发周期、增强复杂分子交付能力等方面，而非直接产生大规模收入。公司的CADD/AIDD技术深度嵌入到业务环节，价值更多体现在高质量的服务溢价、增加客户粘性及业务渗透率等方面。截至2025年12月底，公司CADD/AIDD技术平台已累计为104个新药项目提供技术支持，其中8个项目已进入临床实验阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700039506.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642261339","title":"泓博医药(301230)6月10日股东户数2.05万户，较上期减少0.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2642261339","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642261339?lang=zh_cn&edition=full","pubTime":"2026-06-12 17:36","pubTimestamp":1781257018,"startTime":"0","endTime":"0","summary":"证券之星消息，近日泓博医药披露，截至2026年6月10日公司股东户数为2.05万户，较5月29日减少171.0户，减幅为0.83%。在医疗服务行业个股中，泓博医药股东户数低于行业平均水平，截至6月10日，医疗服务行业平均股东户数为4.82万户。从股价来看，2026年5月29日至2026年6月10日，泓博医药区间跌幅为5.66%，在此期间股东户数减少171.0户，减幅为0.83%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061200027750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642259223","title":"泓博医药：截至2026年6月10日股东户数为20,521户","url":"https://stock-news.laohu8.com/highlight/detail?id=2642259223","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642259223?lang=zh_cn&edition=full","pubTime":"2026-06-12 11:36","pubTimestamp":1781235367,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药(301230)06月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，截至6月10日，公司股东人数多少泓博医药回复：尊敬的投资者您好！根据中登公司下发的股东名册，截至2026年6月10日（交易日），公司的股东户数为20,521户。感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061200014661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642539722","title":"泓博医药：2025年营业收入及盈利能力均实现同比改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2642539722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642539722?lang=zh_cn&edition=full","pubTime":"2026-06-12 09:12","pubTimestamp":1781226739,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药06月11日在投资者关系平台上答复投资者关心的问题。公司2025年营业收入及盈利能力均实现同比改善，经营质量持续提升。目前在手订单、项目推进及客户合作情况整体稳定。公司将持续夯实主业基础，提升运营效率与技术能力，不断增强公司的内在价值，致力于为投资者创造长期、可持续的价值回报。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061200006252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642147034","title":"泓博医药：截至2026年5月29日，公司的股东户数为20,692户","url":"https://stock-news.laohu8.com/highlight/detail?id=2642147034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642147034?lang=zh_cn&edition=full","pubTime":"2026-06-10 11:34","pubTimestamp":1781062440,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药(301230)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘，截至5月31日，公司股东人数多少泓博医药回复：尊敬的投资者您好！根据中登公司下发的股东名册，截至2026年5月29日（交易日），公司的股东户数为20,692户。感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000017330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638914706","title":"泓博医药（301230）披露2024年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告，5月28日股价上涨0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638914706","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638914706?lang=zh_cn&edition=full","pubTime":"2026-05-28 22:27","pubTimestamp":1779978433,"startTime":"0","endTime":"0","summary":"近日，上海泓博智源医药股份有限公司发布《关于2024年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告》。公告显示，公司于2026年5月28日完成2024年限制性股票激励计划首次授予部分第一个归属期的股份归属登记，本次归属日为2026年5月28日，归属股票数量为308,000股，归属对象为23名激励对象，股票来源为公司从二级市场回购的A股普通股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800043278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636834738","title":"泓博医药（301230）披露2025年度持续督导定期现场检查报告，5月19日股价上涨1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636834738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636834738?lang=zh_cn&edition=full","pubTime":"2026-05-19 17:33","pubTimestamp":1779183189,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，泓博医药报收于39.32元，较前一交易日上涨1.21%，最新总市值为54.89亿元。该股当日开盘38.97元，最高39.87元，最低38.89元，成交额达1.65亿元，换手率为3.33%。公告显示，中信证券对泓博医药2025年度持续督导进行了现场检查，检查期间为2025年1月1日至12月31日，现场检查时间为2026年5月12日。现场检查未发现重大问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900032656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636013316","title":"股市必读：泓博医药(301230)股东户数2.29万户，较上期增加0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636013316","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636013316?lang=zh_cn&edition=full","pubTime":"2026-05-18 01:32","pubTimestamp":1779039132,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，泓博医药报收于39.22元，下跌3.14%，换手率5.33%，成交量6.7万手，成交额2.68亿元。股本股东变化股东户数变动近日泓博医药披露，截至2026年5月8日公司股东户数为2.29万户，较4月30日增加185.0户，增幅为0.81%。户均持股数量由上期的6140.0股减少至6090.0股，户均持股市值为25.97万元。公司公告汇总关于举行2025年度网上业绩说明会的公告上海泓博智源医药股份有限公司已于2026年4月29日披露《2025年年度报告》及摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800000653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635038798","title":"泓博医药（301230）披露2025年度网上业绩说明会公告，5月15日股价下跌3.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635038798","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635038798?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:14","pubTimestamp":1778854464,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，泓博医药报收于39.22元，较前一交易日下跌3.14%，最新总市值为54.75亿元。公司于近日披露《关于举行2025年度网上业绩说明会的公告》。公告显示，上海泓博智源医药股份有限公司已于2026年4月29日披露《2025年年度报告》及摘要。公司将于2026年5月22日15:00-16:00在全景网举行2025年度网上业绩说明会，投资者可通过全景网“投资者关系互动平台”参与。公司现面向投资者提前征集问题，征集截止时间为2026年5月21日15:00。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500044010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635784287","title":"泓博医药：截至2026年5月8日股东户数为22,920户","url":"https://stock-news.laohu8.com/highlight/detail?id=2635784287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635784287?lang=zh_cn&edition=full","pubTime":"2026-05-15 09:15","pubTimestamp":1778807733,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药(301230)05月14日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问截止至2026年5月10日收盘公司股东人数为多少，谢谢！泓博医药回复：尊敬的投资者您好！根据中登公司下发的股东名册，截至2026年5月8日（交易日），公司的股东户数为22,920户。感谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500009568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635479242","title":"5月14日泓博医药跌7.41%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635479242","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635479242?lang=zh_cn&edition=full","pubTime":"2026-05-14 16:42","pubTimestamp":1778748147,"startTime":"0","endTime":"0","summary":"证券之星消息，5月14日泓博医药跌7.41%，收盘报40.49元，换手率6.9%，成交量8.66万手，成交额3.67亿元。重仓泓博医药的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为5.33亿元，最新净值1.1879，较上一交易日上涨0.92%，近一年上涨9.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400028876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633125621","title":"泓博医药（301230）披露关于认购基金份额暨关联交易并完成工商变更登记的公告，5月7日股价上涨2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633125621","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633125621?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:58","pubTimestamp":1778147933,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，泓博医药报收于43.63元，较前一交易日上涨2.61%，最新总市值为60.9亿元。近日，泓博医药发布《关于认购基金份额暨关联交易并完成工商变更登记的公告》。该基金主要投资于生物医药健康产业，公司与普通合伙人及其他有限合伙人已签署合伙协议，并完成工商变更登记。本次投资构成与关联方开原亨泰营养科技有限公司的共同投资，属于关联交易，已履行董事会审议程序，无需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700030474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632367461","title":"每周股票复盘：泓博医药（301230）Q1净利增98.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632367461","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632367461?lang=zh_cn&edition=full","pubTime":"2026-05-03 03:01","pubTimestamp":1777748474,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，泓博医药报收于41.4元，较上周的43.36元下跌4.52%。本周关注点业绩披露要点：泓博医药2026年一季度归母净利润同比增长98.59%。股本股东变化截至2026年4月10日，泓博医药股东户数为2.39万户，较3月31日减少1091.0户，减幅为4.36%。预计派发现金股利约27,508,081元（含税），转增后总股本增至180,848,726股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631532389","title":"图解泓博医药一季报：第一季度单季净利润同比增长98.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631532389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631532389?lang=zh_cn&edition=full","pubTime":"2026-04-29 06:17","pubTimestamp":1777414639,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药2026年一季报显示，一季度公司主营收入1.72亿元，同比上升1.69%；归母净利润2377.92万元，同比上升98.59%；扣非净利润645.66万元，同比下降33.32%；负债率21.73%，投资收益680.71万元，财务费用374.47万元，毛利率31.92%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900014775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629201540","title":"4月22日泓博医药涨9.80%，长城消费增值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629201540","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629201540?lang=zh_cn&edition=full","pubTime":"2026-04-22 16:34","pubTimestamp":1776846897,"startTime":"0","endTime":"0","summary":"证券之星消息，4月22日泓博医药涨9.80%，收盘报43.82元，换手率11.11%，成交量13.96万手，成交额5.76亿元。重仓泓博医药的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为长城基金的长城消费增值混合A。长城消费增值混合A目前规模为4.74亿元，最新净值1.1122，较上一交易日下跌1.16%，近一年上涨10.67%。该公募基金现任基金经理为龙宇飞。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200037904.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628798976","title":"股市必读：泓博医药(301230)股东户数2.39万户，较上期减少4.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628798976","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628798976?lang=zh_cn&edition=full","pubTime":"2026-04-20 01:37","pubTimestamp":1776620227,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，泓博医药报收于40.06元，下跌2.36%，换手率5.56%，成交量6.99万手，成交额2.8亿元。股本股东变化股东户数变动近日泓博医药披露，截至2026年4月10日公司股东户数为2.39万户，较3月31日减少1091.0户，减幅为4.36%。户均持股数量由上期的5578.0股增加至5832.0股，户均持股市值为23.25万元。根据中登公司下发的股东名册，截至2026年4月10日（交易日），公司的股东户数为23,935户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000000807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628796282","title":"泓博医药：截至2026年4月10日股东户数为23,935户","url":"https://stock-news.laohu8.com/highlight/detail?id=2628796282","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628796282?lang=zh_cn&edition=full","pubTime":"2026-04-17 16:24","pubTimestamp":1776414264,"startTime":"0","endTime":"0","summary":"证券之星消息，泓博医药(301230)04月17日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年4月15日收盘公司股东人数是多少？谢谢！泓博医药回复：尊敬的投资者您好！根据中登公司下发的股东名册，截至2026年4月10日（交易日），公司的股东户数为23,935户。感谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700030461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301230","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624657429","title":"泓博医药：公司与药石科技未开展相关合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2624657429","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624657429?lang=zh_cn&edition=full","pubTime":"2026-04-03 19:38","pubTimestamp":1775216280,"startTime":"0","endTime":"0","summary":"证券日报网讯4月3日，泓博医药在互动平台回答投资者提问时表示，截至目前，公司与药石科技未开展相关合作。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-04-03/doc-inhtfrev3672977.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-04-03/doc-inhtfrev3672977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0216","300725","BK0229","301230"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782387281223,"stockEarnings":[{"period":"1week","weight":0.1035},{"period":"1month","weight":-0.0201},{"period":"3month","weight":0.058},{"period":"6month","weight":0.2625},{"period":"1year","weight":0.1856},{"period":"ytd","weight":0.2413}],"compareEarnings":[{"period":"1week","weight":0.0007},{"period":"1month","weight":-0.0101},{"period":"3month","weight":0.057},{"period":"6month","weight":0.0371},{"period":"1year","weight":0.2018},{"period":"ytd","weight":0.0358}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海泓博智源医药股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"20521人(较上一季度减少0.83%)","perCapita":"6121股","listingDate":"2022-11-01","address":"上海市浦东新区庆达路315号23幢","registeredCapital":"13958万元","survey":" 上海泓博智源医药股份有限公司的主营业务是药物发现、制药工艺的研究开发以及原料药中间体的商业化生产。公司的主要产品是药物化学、合成化学、药物代谢动力学、工艺化学、工艺开发、药学研究、定制化生产、自主产品生产。","listedPrice":40},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泓博医药(301230)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泓博医药(301230)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泓博医药,301230,泓博医药股票,泓博医药股票老虎,泓博医药股票老虎国际,泓博医药行情,泓博医药股票行情,泓博医药股价,泓博医药股市,泓博医药股票价格,泓博医药股票交易,泓博医药股票购买,泓博医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泓博医药(301230)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泓博医药(301230)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}